Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F.J.F. Herth, A. Ernst, P. Hopkins, J.J. Egan, F. Stanzel, A. Valipour, M. Wagner, C. Witt, K. Baker, M.H. Gotfried, S. Kesten, G. Snell (Heidelberg, , Berlin, Germany; Boston, Iowa City, Phoenix, United States Of America; Chermside, Melbourne, Australia; Vienna, Austria). The influence of emphysema heterogeneity on the magnitude of benefit following endoscopic thermal vapor ablation (InterVaporÔ) in patients with heterogeneous emphysema. Eur Respir J 2012; 40: Suppl. 56, 4724

Member's Comments

No comment yet.

Related content which might interest you: The influence of baseline exercise tolerance on long-term efficacy outcomes following endoscopic thermal vapor ablation (InterVaporÔ) in patients with heterogeneous emphysema Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence Year: 2012 Associations of efficacy outcomes following bronchoscopic thermal vapor ablation (BTVA) for the treatment of heterogeneous emphysema Source: Annual Congress 2011 - Treatment beyond inhalers: endoscopic lung volume reduction Year: 2011 Associations among one-year efficacy outcomes following endoscopic thermal vapor ablation (InterVaporÔ) for heterogeneous emphysema Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence Year: 2012 Germany pilot safety and feasibility study of bronchoscopic thermal vapor ablation (BTVA) for lung volume reduction in patients with heterogeneous emphysema with upper lobe predominance Source: Annual Congress 2009 - Treatment beyond inhalers Year: 2009 Impact of radiological changes on treatment outcome following endoscopic lung volume reduction with coils (LVRC) in patients with advanced emphysema Source: International Congress 2018 – Endoscopic lung volume reduction Year: 2018 The effect of endoscopic lung volume reduction on functional outcomes in patients with severe emphysema. Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients Year: 2019 Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema Source: Eur Respir J 2012; 39: 1326-1333 Year: 2012 Endoscopic lung volume reduction (ELVR) treatment for patients with severe heterogeneous emphysema and bilateral incomplete fissures. Effectiveness and complications of coils´ implantation at 90 days follow up Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015 A safety and feasibility study of the chartis system in subjects with heterogeneous emphysema prior to endobronchial lung volume reduction (ELVR) Source: Annual Congress 2009 - Treatment beyond inhalers Year: 2009 Bronchoscopic lung volume reduction with coils (BLVR-Coils) for treatment of patients with severe heterogeneous emphysema and bilaterally incomplete fissures. Its effectiveness in everyday endoscopic practice Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Targeted vapor ablation as a new method for endoscopic lung volume reduction at segmental level Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016 Endoscopic lung volume reduction with nitinol coils in very severe emphysema: Mid-term effectiveness vs. disease related continuous loss of lung function Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015 Effect of endoscopic lung volume reductions in patients with emphysema – a single center experience Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD Year: 2018 High resolution computed tomography (HRCT) measurements of lobar volume reduction associated with bronchoscopic thermal vapor ablation (BTVA) in patients with heterogeneous emphysema Source: Annual Congress 2011 - Treatment beyond inhalers: endoscopic lung volume reduction Year: 2011 Targeted segmental volume reduction with vapor ablation in emphysema results in reduced RV and clinically meaningful improvement (CMI) in FEV1 Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016 Segmental lung volume reduction (LVR) with vapor better targets disease heterogeneity as compared to lobar LVR Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016 Endobronchial microbiological colonisation in stable COPD patients with severe emphysema undergoing endoscopic lung volume reduction. Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Sustained efficacy from 3 to 6 months following bronchoscopic thermal vapor ablation (BTVA) in the treatment of heterogeneous emphysema Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope? Year: 2011 The minimal important difference for target lobe volume reduction following endoscopic valve therapy in patients with advanced emphysema Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016 Removal of diseased emphysematous tissue with bronchoscopic thermal vapor ablation (BTVA) Source: International Congress 2018 – Endoscopic lung volume reduction Year: 2018